Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis
2006

eNOS Gene and Pre-eclampsia Risk

Sample size: 438 publication Evidence: moderate

Author Information

Author(s): Yu Christina KH, Casas Juan P, Savvidou Makrina D, Sahemey Manpreet K, Nicolaides Kypros H, Hingorani Aroon D

Primary Institution: Harris Birthright Research Centre for Fetal Medicine, King's College, Hospital, Medical School, London, UK

Hypothesis

Is the eNOS Glu298Asp polymorphism associated with an increased risk of pre-eclampsia?

Conclusion

The eNOS Glu298Asp polymorphism is not significantly associated with an increased risk of pre-eclampsia.

Supporting Evidence

  • The study included 89 women with pre-eclampsia and 349 controls.
  • No significant association was found between the eNOS polymorphism and pre-eclampsia risk.
  • The meta-analysis included 12 studies with a total of 1334 cases and 2894 controls.

Takeaway

This study looked at a gene that might affect pregnancy and found that it doesn't really change the chances of getting a condition called pre-eclampsia.

Methodology

A case-control study was conducted with genotyping of the eNOS Glu298Asp polymorphism in women screened for pre-eclampsia, followed by a meta-analysis of existing studies.

Potential Biases

Potential bias due to the underrepresentation of certain ethnic groups in the studies.

Limitations

The studies included may have been underpowered, and larger studies are needed to confirm findings.

Participant Demographics

Women with singleton pregnancies from seven hospitals in London, UK.

Statistical Information

P-Value

0.34

Confidence Interval

95%CI: 0.76–2.16

Statistical Significance

p = 0.34

Digital Object Identifier (DOI)

10.1186/1471-2393-6-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication